89Bio Inc at H.C. Wainwright & Co LLC 7th Annual NASH Investor Conference (Virtual) Transcript
Hello, and welcome again to the seventh annual H.C. Wainwright NASH Investor Conference. My name is Ed Arce, and I'm one of the senior biotech analysts here at HCW. Our next presenting company is 89bio. I'm very pleased to have with us representing the company is CEO Rohan Palekar. Rohan, it's great to see you. Please take it away.
Hey, Ed, thanks for having us at the meeting, and look forward to the discussion. So appreciate it.
Questions & Answers
Right. So let's start from where a lot of the attention is right now in this space, given the readout from two weeks ago with Akero -- the Symmetry readout. Were there any surprises for you there with that result, especially given you have the same mechanism as their drug?
Yeah. And when we look at the Symmetry data, we look at the totality of the data.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
